FLUIDIL Drug Patent Profile
✉ Email this page to a colleague
When do Fluidil patents expire, and when can generic versions of Fluidil launch?
Fluidil is a drug marketed by Pharmacia And Upjohn and is included in one NDA.
The generic ingredient in FLUIDIL is cyclothiazide. Additional details are available on the cyclothiazide profile page.
Summary for FLUIDIL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 57 |
Patent Applications: | 1,230 |
Formulation / Manufacturing: | see details |
DailyMed Link: | FLUIDIL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for FLUIDIL
US Patents and Regulatory Information for FLUIDIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmacia And Upjohn | FLUIDIL | cyclothiazide | TABLET;ORAL | 018173-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |